A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Clinical trial NCT02049489 · COMPLETED

Trial details

NCT number: NCT02049489
Sponsor: Precision Life Sciences Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2013-12-01
Primary completion: 2017-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.